WHY 'HOT' KIDNEY TUMORS DON'T RESPOND TO IMMUNOTHERAPY WITH PD-1 BLOCKERS

Why 'hot' kidney tumors don't respond to immunotherapy with PD-1 blockers aliu Thu, 05/28/2020 - 06:41

CHUTES & LADDERS-IMMUNOMEDICS CEO SEMERJIAN OUT AFTER SHORT TENURE

Chutes & Ladders-Immunomedics CEO Semerjian out after short tenure kblankenship Thu, 05/28/2020 - 14:06

 
 
 

ASCO: ALLOGENE REPORTS 63% RESPONSE RATE IN EARLY TRIAL OF OFF-THE-SHELF CAR-T IN LYMPHOMA

ASCO: Allogene reports 63% response rate in early trial of off-the-shelf CAR-T in lymphoma arlene.weintraub Fri, 05/29/2020 - 08:56

COVID-19 VACCINE LEADERS TALK UP THE NEED FOR PARTNERS, POTENTIAL FOR A WORKING VAX BY OCTOBER

COVID-19 vaccine leaders talk up the need for partners, potential for a working vax by October badams Fri, 05/29/2020 - 04:08

 
 
 

IPSEN NAMES SANOFI PASTEUR CEO LOEW AS NEW LEADER

Ipsen names Sanofi Pasteur CEO Loew as new leader ntaylor Fri, 05/29/2020 - 04:12

TAKEDA DOESN'T HAVE TO DIVEST SHIRE PIPELINE MED AS NO ONE WANTS IT, SO IT TOSSES IT OUT

Takeda doesn't have to divest Shire pipeline med as no one wants it, so it tosses it out badams Fri, 05/29/2020 - 07:06

 
 
 

AFTER PASSING SAFETY HURDLE, ORPHERIS KICK-STARTS COVID-19 CYTOKINE STORM EFFICACY TEST

After passing safety hurdle, Orpheris kick-starts COVID-19 cytokine storm efficacy test badams Thu, 05/28/2020 - 10:05

ANOTHER ALEXION ALUM JOINS RALLYBIO RANKS

Another Alexion alum joins Rallybio ranks badams Thu, 05/28/2020 - 07:13

 
 
 

PROTALIX, CHIESI EDGE CLOSE TO POTENTIAL FABRY DISEASE APPROVAL

Protalix, Chiesi edge close to potential Fabry disease approval badams Thu, 05/28/2020 - 07:50

PURETECH EYES CLINICAL TRIAL IN LONG-TERM COVID-19 COMPLICATIONS

PureTech eyes clinical trial in long-term COVID-19 complications ntaylor Thu, 05/28/2020 - 08:15

 
 
 

STARTUP TARGETS GLIOBLASTOMA TUMORS WITH CAR-T THERAPY

Startup targets glioblastoma tumors with CAR-T therapy aliu Wed, 05/27/2020 - 06:32

THE MONEY KEEPS COMING FOR ELI LILLY COVID-19 PARTNER ABCELLERA WITH $105M ROUND

The money keeps coming for Eli Lilly COVID-19 partner AbCellera with $105M round badams Wed, 05/27/2020 - 05:28

 
 
 

NGOS SLAM 'EXTREMELY DUBIOUS PRIORITIES' OF EU R&D PROGRAM

NGOs slam 'extremely dubious priorities' of EU R&D program ntaylor Wed, 05/27/2020 - 08:09

GILEAD PENS $2B ARCUS PACT FOR IMMUNO-ONCOLOGY TARGETS OF THE PAST AND FUTURE

Gilead pens $2B Arcus pact for immuno-oncology targets of the past and future badams Wed, 05/27/2020 - 08:31

 
 
 

MERCK INKS THEMIS BUYOUT TO JOIN COVID-19 VACCINE RACE

Merck inks Themis buyout to join COVID-19 vaccine race ntaylor Tue, 05/26/2020 - 05:54

TUFTS TEAM REPAIRS BRAIN DEFECTS IN FROGS WITH 'BIOELECTRIC' DRUGS

Tufts team repairs brain defects in frogs with 'bioelectric' drugs arlene.weintraub Tue, 05/26/2020 - 07:23

 
 
 

ARGENX'S AUTOIMMUNE PHASE 3 HITS GOALS, TEEING UP FDA FILING

Argenx's autoimmune phase 3 hits goals, teeing up FDA filing ntaylor Tue, 05/26/2020 - 08:22

CHUTES & LADDERS-WARP SPEED'S SLAOUI SELLS $12M IN MODERNA STOCK

Chutes & Ladders-Warp Speed's Slaoui sells $12M in Moderna stock chale Thu, 05/21/2020 - 15:42

 
 
 

THIS CANCER-RELATED GENE MAY ALSO HOLD THE KEY TO BEATING OBESITY

This cancer-related gene may also hold the key to beating obesity aliu Fri, 05/22/2020 - 06:42

GENENTECH POSTS LONG-TERM DATA ON NEAR-APPROVAL SOLIRIS RIVAL

Genentech posts long-term data on near-approval Soliris rival ntaylor Fri, 05/22/2020 - 08:31

 
 
 



World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two-investigational treatments for sickle cell... Read more ...

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the ASCO conference, the... Read more ...

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

An AbbVie drug that treats pain in the uterus has notched an additional FDA approval for addressing heavy menstrual bleeding associated with uterine fibroids. The regulatory... Read more ...

Daya Bay Reactor Experiment Continues to Generate Data

Daya Bay Reactor Experiment Continues to Generate Data

Antineutrino detectors are submersed in liquid at the Daya Bay experiment, as seen during the final phase of construction in August 2012. Experiment: Daya Bay reactor neutrino... Read more ...

Seeing Cancer, But Not Through a Microscope

Seeing Cancer, But Not Through a Microscope

Toward the end of the 19th century, a French doctor named Ernest Besnier coined the term “ biopsy ,” combining the Greek bios and opsis. In the decades since, clinicians have... Read more ...

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Human DNA holds secrets that, once uncovered, have led scientists to develop a number of treatments for disease. A slew of biopharmas and biotechs-not to mention national... Read more ...

Don't Wait for “Them” to Find Your Weaknesses

Don't Wait for “Them” to Find Your Weaknesses

Our Professional Services Written by: Crystal Booth, M.M.- Regional Manager, Southeast USA at PSC Biotech We've probably all heard the phrase “audit ready state”. But what does... Read more ...

Functional oral nanoparticles for delivering silibinin and cryptotanshinone...

Breast cancer lung metastasis occurs in more than 60% of all patients with breast cancer, and most of those afflicted by it eventually die of recurrence. The tumor... Read more ...

Escherichia coli metabolism under short-term repetitive substrate dynamics...

Microbial metabolism is highly dependent on the environmental conditions. Especially, the substrate concentration, as well as oxygen availability, determine the metabolic... Read more ...

High-yield production of l-serine through a novel identified exporter...

L-Serine has wide and increasing applications in industries with fast-growing market demand. Although strategies for achieving and improving l-serine production in... Read more ...